Home » Topics » Regulatory » Patents

Patents
RSS

New auristatin derivatives for cancer prepared at Bayer Schering Pharma

Jan. 10, 2012

AstraZeneca reports novel dipeptidyl peptidase 1 inhibitors

Jan. 9, 2012

Novel protein-tyrosine kinase inhibitors synthesized in China

Jan. 9, 2012

Novel beta-secretase 1 inhibitors claimed by Janssen Pharmaceutica

Jan. 9, 2012

Afraxis researchers prepare new serine/threonine-protein kinase PAK inhibitors

Jan. 9, 2012

Novel NS5B inhibitors patented by Biota Scientific Management

Jan. 9, 2012

Gilead Sciences discloses new HCV replication inhibitors

Jan. 9, 2012

New HCV NS5B inhibitors synthesized by Arrow Therapeutics and AstraZeneca

Jan. 9, 2012

Researchers at Albany Molecular Research patent novel GlyT-1 inhibitors

Jan. 5, 2012

Enanta Pharmaceuticals designs new compounds for hepatitis C virus infection

Jan. 5, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...